Bank of America Corporation »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $517k 500k 1.03

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Bank of America Corporation

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1